Dr. Shaibani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6624 Fannin St
Suite 1670
Houston, TX 77030Phone+1 713-795-0033Fax+1 713-796-9302
Summary
- nerveandmuscle.org
Education & Training
- Baylor College of MedicineFellowship, Clinical Neurophysiology, 1995
- Baylor College of MedicineResidency, Neurology, 1991 - 1994
- Conemaugh Memorial Medical CenterInternship, Transitional Year, 1990 - 1991
- University of Mosul College of MedicineClass of 1983
Certifications & Licensure
- TX State Medical License 1993 - 2025
- UT State Medical License 1992 - 1994
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
- Efficacy of Methotrexate in Myasthenia Gravis Start of enrollment: 2009 Apr 01
- Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsRandomized Trial of Thymectomy in Myasthenia Gravis.Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, Greg Minisman, Hui-Chien Kuo
The New England Journal of Medicine. 2016-08-11 - 117 citationsLong-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui-Chien Kuo
The Lancet. Neurology. 2019-03-01 - 78 citationsSafety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trialMichael G. Hanna, Umesh A. Badrising, Olivier Benveniste, Thomas E. Lloyd, Merrilee Needham
The Lancet. Neurology. 2019-09-01
Press Mentions
- A Lonestar Tick Bite Could Cause Red Meat AllergyJuly 18th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: